Acitretin for Psoriasis | Therapeutic Cheat Sheet
Pustular psoriasis can present quickly and pose a life-threatening emergency. Acitretin is the only systemic retinoid FDA-approved for treatment of psoriasis, specifically both pustular and severe plaque-type psoriasis.1Systemic retinoids such as acitretin are utilized heavily in dermatology, and practitioners must be knowledgeable about all of the FDA-approved and off-label applications as well a …
Pustular psoriasis can present quickly and pose a life-threatening emergency. Acitretin is the only systemic retinoid FDA-approved for treatment of psoriasis, specifically both pustular and severe plaque-type psoriasis.1Systemic retinoids such as acitretin are utilized heavily in dermatology, and practitioners must be knowledgeable about all of the FDA-approved and off-label applications as well a … Continue reading "Acitretin for Psoriasis | Therapeutic Cheat Sheet"
Sprinkled with many clinical pearls, Dr. Candrice Heath gave us an informative, case-based lecture at the 2021 Skin of Color Update: “Skin Conditions Disproportionately Affecting Pediatric & Adolescent Patients with Skin of Color.” Dr. Heath is an Assistant Professor and Director of Pediatric Dermatology at Lewis Katz School of Medicine at Temple University and is active on social media @D … 
As dermatologists, we understand that hidradenitis suppurativa (HS) can be a devastating disease that affects all aspects of our patients’ lives, influencing their physical health, ability to be active, and ability to be intimate. This disease disproportionately affects patients with skin of color and unfortunately, treatment can be challenging. We are lucky to have experts who dedicate their cl … 
How to Mitigate Risk without Compromising Care
If you were to counsel a patient on every possible risk of a given medication, it would be a long list of extreme and rare potential outcomes and almost certainly leave the patient in doubt whether it is safe even to take. Frequent lab monitoring has been common practice and often used to reduce the perception of risk with systemic medication … 
Case Scenario
A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections. He has not had any gender-affirming surgeries and reports being currently amenorrhoeic. He is curren … 